New antibiotic combo cuts surgical infections in colorectal patients
NCT ID NCT02618720
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether adding an oral antibiotic (ornidazole) the day before colorectal surgery to the standard IV antibiotic given at incision time could reduce surgical site infections within 30 days. Over 900 adults having elective colorectal surgery took part. The goal was to see if the combined approach works better than IV antibiotics alone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
920 people
The number who actually took part.
- Started
-
May 2016
- Finished
-
Jun 2020
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age \> 18 * Laparoscopic or non-laparoscopic elective colorectal surgery Exclusion Criteria: * Non elective colorectal surgery (emergent surgery and/or reintervention or revision of a previous colorectal procedure) * Significant concomitant surgical procedure (e.g., liver resection for metastasis) * Bacterial infection at the time of surgery or antimicrobial therapy up to 2 weeks before surgery * Inflammatory bowel disease * Severe obesity (defined as a BMI \>35 kg/m2) * Known history of hypersensitivity to β-lactams and imidazoles * Preoperative severe impairment in renal function (creatinine clearance (MDRD) \< 30 ml/min) * Patients with known colonization with multidrug-resistant digestive bacteria, especially multidrug-resistant gram-negative bacteria (requiring specific infection control measures) * Allergy to lactose, galactose intolerance, Lapp lactase deficiency or glucose/galactose malabsorption (rare metabolic disease) * Pregnant women, breastfeeding women, women of childbearing age without effective contraceptive- Refusal to participate or inability to provide informed consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Elective colorectal surgery are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Clermont-Ferrand
Clermont-Ferrand, 63003, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.